# Invesco CurrencyShares Japanese Yen Trust: financial statements, quarterly

FXY · NYSE · CIK 1353613 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fxy.md) · [Financials](/companies/fxy/financials.md) · [Filings](/companies/fxy/filings.md) · [Insiders](/companies/fxy/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/fxy/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [0.0](/filings/0000950170-24-122599.md) | [0.0 d](/filings/0000950170-25-027263.md) | [0.0](/filings/0000950170-25-067197.md) | [0.0](/filings/0000950170-25-105148.md) | [0.0](/filings/0001193125-25-270300.md) | [0.0 d](/filings/0001193125-26-083566.md) | [0.0](/filings/0001193125-26-209716.md) | [0.0](/filings/0001193125-26-338718.md) | [0.0](/filings/0001193125-25-270300.md) | [0.0 d](/filings/0001193125-26-083566.md) | [0.0](/filings/0001193125-26-209716.md) | [16.9](/filings/0001193125-26-338718.md) |
| Interest expense | $k | [114](/filings/0000950170-24-122599.md) | [127 d](/filings/0000950170-24-019051.md) | [155](/filings/0000950170-24-054962.md) | [0.1](/filings/0000950170-24-092118.md) | [0.0](/filings/0000950170-24-122599.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $k | [0.0 d](/filings/0000950170-23-060481.md) | [0.0 d](/filings/0000950170-24-019051.md) | [0.0](/filings/0000950170-24-054962.md) | [0.0 d](/filings/0000950170-24-092118.md) | [0.0 d](/filings/0000950170-24-122599.md) | [0.0 d](/filings/0000950170-25-027263.md) | [0.0](/filings/0000950170-25-067197.md) | [0.0 d](/filings/0000950170-25-105148.md) | [0.0 d](/filings/0001193125-25-270300.md) | [0.0 d](/filings/0001193125-26-083566.md) | [0.0](/filings/0001193125-26-209716.md) | [0.0 d](/filings/0001193125-26-338718.md) |
| Net income | $k | [(340)](/filings/0000950170-24-122599.md) | [(377) d](/filings/0000950170-25-027263.md) | [(461)](/filings/0000950170-25-067197.md) | [(353)](/filings/0000950170-25-105148.md) | [(387)](/filings/0001193125-25-270300.md) | [(430) d](/filings/0001193125-26-083566.md) | [(435)](/filings/0001193125-26-209716.md) | [(839)](/filings/0001193125-26-338718.md) | [(630)](/filings/0001193125-25-270300.md) | [(491) d](/filings/0001193125-26-083566.md) | [(477)](/filings/0001193125-26-209716.md) | [(425)](/filings/0001193125-26-338718.md) |
| Diluted EPS | $ per share | [(0.10)](/filings/0000950170-24-122599.md) | not reported | [(0.09)](/filings/0000950170-25-067197.md) | [(0.06)](/filings/0000950170-25-105148.md) | [(0.06)](/filings/0001193125-25-270300.md) | not reported | [(0.06)](/filings/0001193125-26-209716.md) | [(0.06)](/filings/0001193125-26-338718.md) | [(0.06)](/filings/0001193125-25-270300.md) | not reported | [(0.06)](/filings/0001193125-26-209716.md) | [(0.06)](/filings/0001193125-26-338718.md) |
| Basic EPS | $ per share | [(0.10)](/filings/0000950170-24-122599.md) | not reported | [(0.09)](/filings/0000950170-25-067197.md) | [(0.06)](/filings/0000950170-25-105148.md) | [(0.06)](/filings/0001193125-25-270300.md) | not reported | [(0.06)](/filings/0001193125-26-209716.md) | [(0.06)](/filings/0001193125-26-338718.md) | [(0.06)](/filings/0001193125-25-270300.md) | not reported | [(0.06)](/filings/0001193125-26-209716.md) | [(0.06)](/filings/0001193125-26-338718.md) |

- Revenue: us-gaap:Revenues
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [218](/filings/0000950170-23-060481.md) | [313](/filings/0000950170-25-027263.md) | [343](/filings/0000950170-24-054962.md) | [339](/filings/0000950170-24-092118.md) | [469](/filings/0000950170-24-122599.md) | [391](/filings/0001193125-26-083566.md) | [549](/filings/0000950170-25-067197.md) | [823](/filings/0000950170-25-105148.md) | [545](/filings/0001193125-25-270300.md) | [475](/filings/0001193125-26-338718.md) | [468](/filings/0001193125-26-209716.md) | [429](/filings/0001193125-26-338718.md) |
| Current assets | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | not reported | [313](/filings/0000950170-25-027263.md) | [343](/filings/0000950170-24-054962.md) | [339](/filings/0000950170-24-092118.md) | [469](/filings/0000950170-24-122599.md) | [394](/filings/0001193125-26-083566.md) | [549](/filings/0000950170-25-067197.md) | [823](/filings/0000950170-25-105148.md) | [545](/filings/0001193125-25-270300.md) | [475](/filings/0001193125-26-338718.md) | [468](/filings/0001193125-26-209716.md) | [429](/filings/0001193125-26-338718.md) |
| Current liabilities | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total liabilities | $m | [0.1](/filings/0000950170-23-060481.md) | [0.1](/filings/0000950170-25-027263.md) | [0.2](/filings/0000950170-24-054962.md) | [0.1](/filings/0000950170-24-092118.md) | [0.1](/filings/0000950170-24-122599.md) | [3.1](/filings/0001193125-26-083566.md) | [0.2](/filings/0000950170-25-067197.md) | [0.3](/filings/0000950170-25-105148.md) | [0.2](/filings/0001193125-25-270300.md) | [0.2](/filings/0001193125-26-338718.md) | [0.2](/filings/0001193125-26-209716.md) | [0.1](/filings/0001193125-26-338718.md) |

- Cash and equivalents: us-gaap:Cash
- Current assets: not reported
- Total assets: us-gaap:Assets
- Current liabilities: not reported
- Total liabilities: us-gaap:Liabilities

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(366) d](/filings/0000950170-24-122599.md) | [(334) d](/filings/0000950170-25-027263.md) | [(452)](/filings/0000950170-25-067197.md) | [(402) d](/filings/0000950170-25-105148.md) | [(356) d](/filings/0001193125-25-270300.md) | [(432) d](/filings/0001193125-26-083566.md) | [(397)](/filings/0001193125-26-209716.md) | [(733) d](/filings/0001193125-26-338718.md) | [(727) d](/filings/0001193125-25-270300.md) | [(514) d](/filings/0001193125-26-083566.md) | [(473)](/filings/0001193125-26-209716.md) | [(464) d](/filings/0001193125-26-338718.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [2.5](/filings/0000950170-23-060481.md) | [3.3](/filings/0000950170-24-054962.md) | [3.8](/filings/0000950170-24-092118.md) | [3.5](/filings/0000950170-24-122599.md) | [5.0](/filings/0000950170-25-067197.md) | [6.0](/filings/0000950170-25-105148.md) | [6.2](/filings/0001193125-25-270300.md) | [7.3](/filings/0001193125-26-209716.md) | [13.3](/filings/0001193125-26-338718.md) | [9.9](/filings/0001193125-25-270300.md) | [8.2](/filings/0001193125-26-209716.md) | [7.7](/filings/0001193125-26-338718.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 7,600,000 at 2026-06-30, from the cover of the [10-Q filed 2026-08-07](/filings/0001193125-26-338718.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:37 ET. No prices; not investment advice.